Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy

Our objective was to investigate whether photodynamic therapy (PDT) influences the expression of HLA Class I and β2-microglobulin molecules on cultured uveal melanoma cells. Uveal melanoma cells were incubated with hematoporphyrin esters (HPE) and illuminated using red light. HLA expression on cells...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 1997-01, Vol.112 (2), p.239-243
Hauptverfasser: Blom, Derk-Jan R., Schuitmaker, Hans J., de Waard-Siebinga, Itte, Dubbelman, Tom M.A.R., Jager, Martine J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 243
container_issue 2
container_start_page 239
container_title Cancer letters
container_volume 112
creator Blom, Derk-Jan R.
Schuitmaker, Hans J.
de Waard-Siebinga, Itte
Dubbelman, Tom M.A.R.
Jager, Martine J.
description Our objective was to investigate whether photodynamic therapy (PDT) influences the expression of HLA Class I and β2-microglobulin molecules on cultured uveal melanoma cells. Uveal melanoma cells were incubated with hematoporphyrin esters (HPE) and illuminated using red light. HLA expression on cells was determined by flowcytometry. PDT treatment induced an immediate reduction in expression of HLA Class I and β2-microglobulin, followed by a transient increase in expression after 2 h. Normalization occurred after 6 h. Treatment of ocular melanoma cells with PDT temporally alters the expression of HLA Class I and β2-microglobulin, which may affect anti-tumor-immune responses.
doi_str_mv 10.1016/S0304-3835(96)04578-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78882355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383596045788</els_id><sourcerecordid>15964403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-44b0edeadc3037e81c8fffb256a2b49cca2d7a7168ee0afe4a8d09c1a1ecdf543</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EKtvCT6jkA0L0EGrHduKcUNUWWmklDsDZmrXH1MiJg50t7L9v0l3ttaeRZr55M3qPkHPOPnPGm8sfTDBZCS3Up665YFK1utKvyIrrtq7aTrPXZHVE3pLTUv4wxpRs1Qk56VjTtEKuiLtBmxEKOor_x4ylhDTQ5Ond-oraCKXQe7p07DZCpj1GGFIP1GKMhfoUY_oXht80DPQxTDnR8SFNye0G6IOl0wNmGHfvyBsPseD7Qz0jv77e_ry-q9bfv91fX60rK2s2VVJuGDoEZwUTLWputfd-U6sG6o3srIXatdDyRiMy8ChBO9ZZDhyt80qKM_Jxrzvm9HeLZTJ9KMunMGDaFtNqrWuh1IsgV10jJRMzqPagzamUjN6MOfSQd4Yzs8RgnmMwi8ema8xzDEbPe-eHA9tNj-64dfB9nn84zKFYiD7DYEM5YrXqZqVF5ssew9m1x4DZFBtwsOhCRjsZl8ILjzwBRx2mCw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15964403</pqid></control><display><type>article</type><title>Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Blom, Derk-Jan R. ; Schuitmaker, Hans J. ; de Waard-Siebinga, Itte ; Dubbelman, Tom M.A.R. ; Jager, Martine J.</creator><creatorcontrib>Blom, Derk-Jan R. ; Schuitmaker, Hans J. ; de Waard-Siebinga, Itte ; Dubbelman, Tom M.A.R. ; Jager, Martine J.</creatorcontrib><description>Our objective was to investigate whether photodynamic therapy (PDT) influences the expression of HLA Class I and β2-microglobulin molecules on cultured uveal melanoma cells. Uveal melanoma cells were incubated with hematoporphyrin esters (HPE) and illuminated using red light. HLA expression on cells was determined by flowcytometry. PDT treatment induced an immediate reduction in expression of HLA Class I and β2-microglobulin, followed by a transient increase in expression after 2 h. Normalization occurred after 6 h. Treatment of ocular melanoma cells with PDT temporally alters the expression of HLA Class I and β2-microglobulin, which may affect anti-tumor-immune responses.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(96)04578-8</identifier><identifier>PMID: 9066734</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Antigens, Neoplasm - biosynthesis ; beta 2-Microglobulin - biosynthesis ; Biological and medical sciences ; Flow Cytometry ; Hematoporphyrins - pharmacology ; Histocompatibility Antigens Class I - biosynthesis ; HLA Class I antigens ; Humans ; Medical sciences ; Melanoma - drug therapy ; Melanoma - metabolism ; Photochemotherapy ; Photodynamic treatment ; Photoradiation therapy and photosensitizing agent ; Photosensitizing Agents - pharmacology ; Treatment with physical agents ; Treatment. General aspects ; Tumor Cells, Cultured ; Tumors ; Uveal melanoma ; Uveal Neoplasms - drug therapy ; Uveal Neoplasms - metabolism</subject><ispartof>Cancer letters, 1997-01, Vol.112 (2), p.239-243</ispartof><rights>1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-44b0edeadc3037e81c8fffb256a2b49cca2d7a7168ee0afe4a8d09c1a1ecdf543</citedby><cites>FETCH-LOGICAL-c420t-44b0edeadc3037e81c8fffb256a2b49cca2d7a7168ee0afe4a8d09c1a1ecdf543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0304-3835(96)04578-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2590458$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9066734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blom, Derk-Jan R.</creatorcontrib><creatorcontrib>Schuitmaker, Hans J.</creatorcontrib><creatorcontrib>de Waard-Siebinga, Itte</creatorcontrib><creatorcontrib>Dubbelman, Tom M.A.R.</creatorcontrib><creatorcontrib>Jager, Martine J.</creatorcontrib><title>Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Our objective was to investigate whether photodynamic therapy (PDT) influences the expression of HLA Class I and β2-microglobulin molecules on cultured uveal melanoma cells. Uveal melanoma cells were incubated with hematoporphyrin esters (HPE) and illuminated using red light. HLA expression on cells was determined by flowcytometry. PDT treatment induced an immediate reduction in expression of HLA Class I and β2-microglobulin, followed by a transient increase in expression after 2 h. Normalization occurred after 6 h. Treatment of ocular melanoma cells with PDT temporally alters the expression of HLA Class I and β2-microglobulin, which may affect anti-tumor-immune responses.</description><subject>Antigens, Neoplasm - biosynthesis</subject><subject>beta 2-Microglobulin - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Flow Cytometry</subject><subject>Hematoporphyrins - pharmacology</subject><subject>Histocompatibility Antigens Class I - biosynthesis</subject><subject>HLA Class I antigens</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - metabolism</subject><subject>Photochemotherapy</subject><subject>Photodynamic treatment</subject><subject>Photoradiation therapy and photosensitizing agent</subject><subject>Photosensitizing Agents - pharmacology</subject><subject>Treatment with physical agents</subject><subject>Treatment. General aspects</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Uveal melanoma</subject><subject>Uveal Neoplasms - drug therapy</subject><subject>Uveal Neoplasms - metabolism</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EKtvCT6jkA0L0EGrHduKcUNUWWmklDsDZmrXH1MiJg50t7L9v0l3ttaeRZr55M3qPkHPOPnPGm8sfTDBZCS3Up665YFK1utKvyIrrtq7aTrPXZHVE3pLTUv4wxpRs1Qk56VjTtEKuiLtBmxEKOor_x4ylhDTQ5Ond-oraCKXQe7p07DZCpj1GGFIP1GKMhfoUY_oXht80DPQxTDnR8SFNye0G6IOl0wNmGHfvyBsPseD7Qz0jv77e_ry-q9bfv91fX60rK2s2VVJuGDoEZwUTLWputfd-U6sG6o3srIXatdDyRiMy8ChBO9ZZDhyt80qKM_Jxrzvm9HeLZTJ9KMunMGDaFtNqrWuh1IsgV10jJRMzqPagzamUjN6MOfSQd4Yzs8RgnmMwi8ema8xzDEbPe-eHA9tNj-64dfB9nn84zKFYiD7DYEM5YrXqZqVF5ssew9m1x4DZFBtwsOhCRjsZl8ILjzwBRx2mCw</recordid><startdate>19970130</startdate><enddate>19970130</enddate><creator>Blom, Derk-Jan R.</creator><creator>Schuitmaker, Hans J.</creator><creator>de Waard-Siebinga, Itte</creator><creator>Dubbelman, Tom M.A.R.</creator><creator>Jager, Martine J.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19970130</creationdate><title>Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy</title><author>Blom, Derk-Jan R. ; Schuitmaker, Hans J. ; de Waard-Siebinga, Itte ; Dubbelman, Tom M.A.R. ; Jager, Martine J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-44b0edeadc3037e81c8fffb256a2b49cca2d7a7168ee0afe4a8d09c1a1ecdf543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antigens, Neoplasm - biosynthesis</topic><topic>beta 2-Microglobulin - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Flow Cytometry</topic><topic>Hematoporphyrins - pharmacology</topic><topic>Histocompatibility Antigens Class I - biosynthesis</topic><topic>HLA Class I antigens</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - metabolism</topic><topic>Photochemotherapy</topic><topic>Photodynamic treatment</topic><topic>Photoradiation therapy and photosensitizing agent</topic><topic>Photosensitizing Agents - pharmacology</topic><topic>Treatment with physical agents</topic><topic>Treatment. General aspects</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Uveal melanoma</topic><topic>Uveal Neoplasms - drug therapy</topic><topic>Uveal Neoplasms - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blom, Derk-Jan R.</creatorcontrib><creatorcontrib>Schuitmaker, Hans J.</creatorcontrib><creatorcontrib>de Waard-Siebinga, Itte</creatorcontrib><creatorcontrib>Dubbelman, Tom M.A.R.</creatorcontrib><creatorcontrib>Jager, Martine J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blom, Derk-Jan R.</au><au>Schuitmaker, Hans J.</au><au>de Waard-Siebinga, Itte</au><au>Dubbelman, Tom M.A.R.</au><au>Jager, Martine J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1997-01-30</date><risdate>1997</risdate><volume>112</volume><issue>2</issue><spage>239</spage><epage>243</epage><pages>239-243</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>Our objective was to investigate whether photodynamic therapy (PDT) influences the expression of HLA Class I and β2-microglobulin molecules on cultured uveal melanoma cells. Uveal melanoma cells were incubated with hematoporphyrin esters (HPE) and illuminated using red light. HLA expression on cells was determined by flowcytometry. PDT treatment induced an immediate reduction in expression of HLA Class I and β2-microglobulin, followed by a transient increase in expression after 2 h. Normalization occurred after 6 h. Treatment of ocular melanoma cells with PDT temporally alters the expression of HLA Class I and β2-microglobulin, which may affect anti-tumor-immune responses.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9066734</pmid><doi>10.1016/S0304-3835(96)04578-8</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1997-01, Vol.112 (2), p.239-243
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_78882355
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Antigens, Neoplasm - biosynthesis
beta 2-Microglobulin - biosynthesis
Biological and medical sciences
Flow Cytometry
Hematoporphyrins - pharmacology
Histocompatibility Antigens Class I - biosynthesis
HLA Class I antigens
Humans
Medical sciences
Melanoma - drug therapy
Melanoma - metabolism
Photochemotherapy
Photodynamic treatment
Photoradiation therapy and photosensitizing agent
Photosensitizing Agents - pharmacology
Treatment with physical agents
Treatment. General aspects
Tumor Cells, Cultured
Tumors
Uveal melanoma
Uveal Neoplasms - drug therapy
Uveal Neoplasms - metabolism
title Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A52%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20expression%20of%20HLA%20class%20I%20on%20ocular%20melanoma%20cells%20following%20in%20vitro%20photodynamic%20therapy&rft.jtitle=Cancer%20letters&rft.au=Blom,%20Derk-Jan%20R.&rft.date=1997-01-30&rft.volume=112&rft.issue=2&rft.spage=239&rft.epage=243&rft.pages=239-243&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(96)04578-8&rft_dat=%3Cproquest_cross%3E15964403%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15964403&rft_id=info:pmid/9066734&rft_els_id=S0304383596045788&rfr_iscdi=true